Stryker CorpSYK
Price$272.96Intrinsic value$366.0534% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $366.05median of 6 methods · middle span $312-$417based on filings through 30 Jun 2026
Market Price $272.96Price as of 1 Oct 2026
Margin of Safety +34.1%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 15.2% (near-term consensus, capped) · years 2–5: 10.0%/yr (balance of the path).11.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.5%Yr 79.0%Yr 88.4%Yr 97.9%Yr 107.4%
10.0% → 7.4%
Years 11–20: glide to long-run rate
Per-year rates
Yr 116.9%Yr 126.5%Yr 136.1%Yr 145.6%Yr 155.2%Yr 164.8%Yr 174.3%Yr 183.9%Yr 193.4%Yr 203.0%
7.4% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)7.4%
Discount rate (cost of equity) 8.7%
Volatility vs market (adjusted beta)0.84

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetStryker CorpSYKHealth Care
Valuation
P/E28.3×
P/S4.2×
P/B4.5×
EV / Revenue4.6×
EV / EBITDA—
Profitability
Gross margin65.0%
Operating margin21.4%
Net margin14.4%
FCF margin18.2%
Returns
ROE15.5%
ROA7.8%
ROIC10.5%
Growth
Revenue growth (YoY)14.3%
5-yr fwd EPS growth11.0%
Financial strength
Debt / Equity0.62×
Current ratio2.16×
Altman Z-Score4.4
Interest coverage—
Dividend yield0.6%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.